Under construction – not a live service
Sign in
Taking people in PakistanNo phase

Eccentric vs Low-Load Blood Flow Restriction Training in Knee Osteoarthritis in Knee Osteoarthritis

Key facts

Where
Rawalpindi, PakistanSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 40 and 70 years old?

Source: NCT07733518, who can take part

Where in Pakistan

  • Railway General Hospital, RawalpindiRawalpindi, PakistanContact: KINZA ANWAR, MS-OMPTTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Riphah International University
Trial code
NCT07733518
Record updated
7 August 2026
Original description
The aim of this randomized controlled trial is to find the effects of eccentric and low-load blood flow restriction training on neuromuscular adaptations, muscle strength, functional performance, and disability in patients with knee osteoarthritisRead full original descriptionShow less

Comparison of Eccentric and Low-Load Blood Flow Restriction Training on Neuromuscular Adaptations in Knee Osteoarthritis

The aim of this randomized controlled trial is to find the effects of eccentric and low-load blood flow restriction training on neuromuscular adaptations, muscle strength, functional performance, and disability in patients with knee osteoarthritis

Inclusion: Age group 40-70; Both genders male and female; Clinical diagnosis of knee OA (Kellgren-Lawrence grade 1-3) of the most symptomatic knee; Pain stable enough to permit exercise on Numeric Pain Rating Scale 3/10; Participants must demonstrate a gastrocnemius muscle strength of grade ≥3 on the Manual Muscle Testing (MMT) scale (0-5), assessed using the standard standing heel-rise position; Participants must be able to ambulate independently and participate in supervised exercise.

Exclusion: • Presence of a prosthetic knee in the affected limb; Inflammatory arthritis (e.g., rheumatoid arthritis) or active flare-up of OA; Cardiovascular disease contraindicating exercise (e.g., unstable angina, recent MI, uncontrolled hypertension ≥160/100 mmHg); Pulmonary disease that limits safe participation (e.g., severe COPD, recent exacerbation); History of deep vein thrombosis (DVT), peripheral vascular disease, or bleeding/clotting disorders; Current anticoagulant therapy that increases bleeding risk (unless cleared by physician); Any pathology causing significant muscle weakness (e.g., neuromuscular disorders, severe neuropathy).

ClinicalTrials.gov NCT07733518